Kobo Biotech

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE881A01015
  • NSEID:
  • BSEID: 531541
INR
2.23
-0.08 (-3.46%)
BSENSE

Dec 05

BSE+NSE Vol: 12.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Kobo Biotech Ltd stock-summary
stock-summary
Kobo Biotech Ltd
Micro Cap
Commodity Chemicals
Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992. Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited. The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).
Company Coordinates stock-summary
Company Details
Ground Flr D No 8-2-684/J/8/A, Bhavani Nagar Banjara Hills Hyderabad Telangana : 500034
stock-summary
Tel:
stock-summary
stock-summary
info@avonlifesciences.com
Registrar Details
XL Softech Systems Ltd , 3 Sagar Society Road , No 2 Banjara Hills, Hyderabad
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 23.52 Cr
Number of Shares
2.35 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Apr-2016
2.35
23.52
100000
10
Conversion of Warrants
11-Apr-2016
2.35
23.52
100000
10
Conversion of Warrants
08-Dec-2015
2.34
23.43
100000
10
Conversion of Warrants
08-Dec-2015
2.34
23.43
100000
10
Conversion of Warrants
27-Nov-2015
2.33
23.32
100000
10
Conversion of Warrants
27-Nov-2015
2.33
23.32
100000
10
Conversion of Warrants
06-Nov-2015
2.32
23.23
100000
10
Conversion of Warrants
06-Nov-2015
2.32
23.23
100000
10
Conversion of Warrants
04-Nov-2015
2.31
23.12
300000
10
Conversion of Warrants
04-Nov-2015
2.31
23.12
300000
10
Conversion of Warrants
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Arch Pharmalabs Ltd (44.95%)

Highest Public shareholder

Mehul Pravin Chandra Shah (1.1%)

Individual Investors Holdings

48.27%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Ajit Kamath
Chairman (Non-Executive)
0
Rajendra Kaimal
Non-Exec & Non-Independent Dir
0
Jignesh Patel
Company Sec. & Compli. Officer
0
Sunil Pitroda
Non-Exec. & Independent Dir.
0
Abhishek Buddhadev
Non-Exec. & Independent Dir.
0
Urja Shah
Non-Exec. & Independent Dir.
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Intermediates & APIs
32.54
99.64%
 
99.64
Intermediates & APIs
0.36
Intermediates & APIs
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2024)
Net Profit:
-1 Cr
stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 5 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

40

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-1.05

stock-summary
Return on Equity

3.71%

stock-summary
Price to Book

-0.04